4.7 Article

Establishing an Artificial Pathway for Efficient Biosynthesis of Hydroxytyrosol

期刊

ACS SYNTHETIC BIOLOGY
卷 7, 期 2, 页码 647-654

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acssynbio.7b00385

关键词

hydroxytyrosol; microbial synthesis; shikimate pathway; biphasic cultivation; 4-hydroxyphenylacetic acid 3-hydroxylase

资金

  1. National Natural Science Foundation of China [21606012, 21636001, 21776008]
  2. Fundamental Research Funds for the Central Universities [buctrc201613]

向作者/读者索取更多资源

Hydroxytyrosol (HT) is a valuable natural phenolic compound with strong antioxidant activity and various physiological and pharmaceutical functions. In this study, we established an artificial pathway for HT biosynthesis. First, efficient enzymes were selected to construct a tyrosol biosynthetic pathway. Aro10 from Saccharomyces cerevisiae was shown to be a better ketoacid decarboxylase than Kivd from Lactococcus lactis for tyrosol production. While knockout of feaB significantly decreased accumulation of the byproduct 4-hydroxyphenylacetic acid, overexpression of alcohol dehydrogenase ADH6 further improved tyrosol production. The titers of tyrosol reached 1469 +/- 56 mg/L from tyrosine and 620 +/- 23 mg/L from simple carbon sources, respectively. The pathway was further extended for HT production by overexpressing Escherichia coli native hydroxylase HpaBC. To enhance transamination of tyrosine to 4-hydroxyphenylpyruvate, NH4Cl was removed from the culture media. To decrease oxidation of HT, ascorbic acid was added to the cell culture. To reduce the toxicity of HT, 1-dodecanol was selected as the extractant for in situ removal of HT. These efforts led to an additive increase in HT titer to 1243 +/- 165 mg/L in the feeding experiment. Assembly of the full pathway resulted in 647 +/- 35 mg/L of HT from simple carbon sources. This work provides a promising alternative for sustainable production of HT, which shows scale-up potential.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据